Skip to Content
Merck
All Photos(1)

Documents

E2499901

Etofenamate for peak identification

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Etofenamate, 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C18H18F3NO4
CAS Number:
30544-47-9
Molecular Weight:
369.34
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

etofenamate

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

InChI

1S/C18H18F3NO4/c19-18(20,21)13-4-3-5-14(12-13)22-16-7-2-1-6-15(16)17(24)26-11-10-25-9-8-23/h1-7,12,22-23H,8-11H2

InChI key

XILVEPYQJIOVNB-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Etofenamate for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Pictograms

Skull and crossbonesEnvironment
GHS06,GHS09

Signal Word

Danger

Hazard Statements

H301,H410

Hazard Classifications

Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Allergic contact dermatitis from etofenamate without cross-sensitization to other anthranilic acid derivatives.
Chia-Yu Chu et al.
Dermatology (Basel, Switzerland), 206(4), 341-342 (2003-05-29)
A Degenhardt et al.
Zeitschrift fur Hautkrankheiten, 63(6), 475-478 (1988-06-15)
We report on 3 cases of contact dermatitis following topical application of etofenamat. Each patient developed positive reactions in patch tests with etofenamat in concentrations of both 10% and 1%. After testing, one patient showed secondary inflammatory reactions at the
R Knöll et al.
Sportverletzung Sportschaden : Organ der Gesellschaft fur Orthopadisch-Traumatologische Sportmedizin, 4(2), 96-98 (1990-06-01)
A typical case of contact dermatitis following topical applications of etofenamat is reported and a short review of literature is given. Considering the frequent administration of etofenamat, contact sensitization is relatively rare.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service